Like an addict's growing resistance to his drug of choice, requiring larger and larger doses to achieve the same effect, markets appear to have built up their resistance to Dr. Fed's prescription of Quantitative Easing, as RIA Advisors' Chief Investment Strategist, Lance Roberts, and Portfolio Manager, Michael Lebowitz, discuss.